DCTH Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Delcath Systems Inc (DCTH) is not a strong buy at the moment for a beginner investor with a long-term strategy and $50,000-$100,000 available for investment. The technical indicators show a bearish trend, and the company's financial performance, while showing revenue growth, is burdened by declining net income and EPS. Analysts maintain a Buy rating but have lowered the price target, citing increased expenses for growth. With no recent news or significant trading trends, and no strong proprietary trading signals, it is better to hold off on investing in this stock right now.
The MACD is positive and expanding, indicating some bullish momentum, but the RSI is neutral at 56.306, providing no clear signal. The moving averages are bearish (SMA_200 > SMA_20 > SMA_5), and the stock is trading below key resistance levels (R1: 9.571, R2: 9.857). The stock has a 90% chance of dropping -2.6% in the next day, though it may rise 12.97% in the next month.
The company has shown strong revenue growth in Q4 2025 (up 37.27% YoY), and analysts believe increased R&D and SG&A expenses will drive long-term growth for HEPZATO and label expansion.
Net income (-44.20% YoY) and EPS (-54.55% YoY) have significantly declined. Gross margin has also slightly dropped. Analysts have lowered the price target from $29 to $27 due to concerns over 2026 guidance. No recent news or significant insider/hedge fund trading trends.
In Q4 2025, revenue increased by 37.27% YoY to $20.73M. However, net income dropped by -44.20% YoY to -$1.896M, and EPS fell by -54.55% YoY to -$0.05. Gross margin slightly declined to 85.48%.
Analysts maintain a Buy rating but have lowered the price target from $29 to $27. They cite increased expenses for growth as a long-term positive but acknowledge near-term weakness due to concerns over 2026 guidance.
